Development and validation of RP-HPLC method for estimation of silodosin in bulk and pharmaceutical dosage forms

International Journal of Pharmaceutical Sciences Review and Research

Volumn 16, Issue 2, 2012, Pages 52-55

  Runja, Chinnalalaiah ^a   Pigili, Ravikumar ^a  

^a Joginpally BRPharmacy College   (India)

Author keywords

RP HPLC; Silodosin; Validation

Indexed keywords

AMMONIUM ACETATE; BUFFER; SILODOSIN;

ACCURACY; ARTICLE; BULK DENSITY; CORRELATION COEFFICIENT; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG STRUCTURE; FLOW RATE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PH; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 84868268607     PISSN: 0976044X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. th edition, Merck & Co., White house station, New Jersey. 2006: pp 1467
2. Francesco Montorsi. Profile of silodosin, European urology supplement. 9: (2010), 491-495.
3. Yoshida M, Homma Y, Kawabe K. Silodosin, a novel selective alpha 1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia. Expert Opin Investig Drugs. 16 (12): 2007, 1955-65.
4. Zhao X, Liu Y, Xu J, Zhang D, Zhou Y, Gu J, Cui Y. Determination of silodosin in human plasma by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B. 877(29), 2009, 3724-3728.
5. C R Sharma, J Akhtar, N M Jagani, Y R Shankharva, J S Shah. UV Spectrophotometric method for estimation of silodosin from its solid dosage form. Inventi Rapid: Pharm Analysis & Quality Assurance. 3, 2012, 310.